Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Raed Kensara"'
Autor:
Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Daniah AlMohammady, Amjaad Alfahed, Elaf F. Altebainawi, Mohammed Aldhaeefi, Hisham A. Badreldin, Ramesh Vishwakarma, Faisal E. Almutairi, Abeer A. Alenazi, Thamer Alsulaiman, Rahaf Ali Alqahtani, Fahad Al Dhahri, Namareq Aldardeer, Ahmed O. Alenazi, Shmeylan Al Harbi, Raed Kensara, Mai Alalawi, Khalid Al Sulaiman
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Dexamethasone usually recommended for patients with severe coronavirus disease 2019 (COVID-19) to reduce short-term mortality. However, it is uncertain if another corticosteroid, such as methylprednisolone, may be utilized to obta
Externí odkaz:
https://doaj.org/article/b7fe4e5cd2af4e15af7d79e9ac4300b2
Autor:
Khalid Al Sulaiman, Ghazwa B. Korayem, Ali F. Altebainawi, Shmeylan Al Harbi, Abdulrahman Alissa, Abdullah Alharthi, Raed Kensara, Amjaad Alfahed, Ramesh Vishwakarma, Hussain Al Haji, Naif Almohaimid, Omar Al Zumai, Fahad Alrubayan, Abdulmajid Asiri, Nasser Alkahtani, Abdulaziz Alolayan, Samiah Alsohimi, Nawal Melibari, Alaa Almagthali, Seba Aljahdali, Abeer A. Alenazi, Alawi S. Alsaeedi, Ghassan Al Ghamdi, Omar Al Faris, Joud Alqahtani, Jalal Al Qahtani, Khalid A. Alshammari, Khalil I. Alshammari, Ohoud Aljuhani
Publikováno v:
Critical Care, Vol 26, Iss 1, Pp 1-12 (2022)
Abstract Background Inhaled nitric oxide (iNO) is used as rescue therapy in patients with refractory hypoxemia due to severe COVID-19 acute respiratory distress syndrome (ARDS) despite the recommendation against the use of this treatment. To date, th
Externí odkaz:
https://doaj.org/article/94bb3562bde54de2990dc4df12fb7432
Autor:
Ghazwa B. Korayem, Ohoud Aljuhani, Ali F. Altebainawi, Abdulrahman I. Al Shaya, Lina I. Alnajjar, Abdulrahman Alissa, Mohammed Aldhaeefi, Raed Kensara, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Omar Alhuthaili, Ramesh Vishwakarma, Namareq Aldardeer, Khalid Eljaaly, Aisha Alharbi, Shmeylan Al Harbi, Abdulmalik Al Katheri, Abdulkareem M. Al Bekairy, Ahmed Aljedai, Khalid Al Sulaiman
Publikováno v:
International Journal of Infectious Diseases, Vol 122, Iss , Pp 252-259 (2022)
ABSTRACT: Objectives: Evidence supports tocilizumab (TCZ) benefit and safety in adult patients with severe COVID-19. However, its effectiveness in critically ill older adult patients remains questionable. Thus, the study aimed to evaluate the safety
Externí odkaz:
https://doaj.org/article/145f3c9134124608801970a63d78ac89
Autor:
Raed Kensara BSc.Pharm, SCC-CCP, BCPS, Ohoud Aljuhani PharmD, Ghazwa B Korayem PharmD, Hadeel Alkofide PhD, Sumaya N Almohareb PharmD, Yousef S Alosaimi PharmD, Ali F Altebainawi PharmD, Khalid Bin saleh PharmD, Norah Al Andas PharmD, MClinPharm, Shmeylan Al Harbi PharmD, Abdullah F Al Harthi PharmD, BCCCP, Uhood Ashkan PharmD, Rema Alghamdi PharmD, Hisham A Badreldin PharmD, Awatif Hafiz PharmD, Mashael AlFaifi PharmD, Rahaf A Alqahtani PharmD, Ramesh Vishwakarma PhD, Abeer A Alenazi PharmD, Mai Alalawi PharmD, Reem mahboob BSc.pharm, Renad A Alfouzan PharmD, Layan B Al Tuhayni PharmD, Nouf Al Qahtani BSc.pharm, MSc Med. Ed, Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Atrial fibrillation (Afib) can contribute to a significant increase in mortality and morbidity in critically ill patients. Thus, our study aims to investigate the incidence and clinical outcomes associated with the new-onset Afib in critically ill pa
Externí odkaz:
https://doaj.org/article/1ccd8ccd0378447f876bc769638f9f11
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Abdulrahman I. Al Shaya, Abdullah Kharbosh, Raed Kensara, Alhomaidi Al Guwairy, Aisha Alharbi, Rahmah Algarni, Shmeylan Al Harbi, Ramesh Vishwakarma, Ghazwa B. Korayem
Publikováno v:
Critical Care, Vol 25, Iss 1, Pp 1-8 (2021)
Abstract Background Zinc is a trace element that plays a role in stimulating innate and acquired immunity. The role of zinc in critically ill patients with COVID-19 remains unclear. This study aims to evaluate the efficacy and safety of zinc sulfate
Externí odkaz:
https://doaj.org/article/19d5ca74610a44708393596dd4f24ae9
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Shmeylan Al Harbi, Abdulrahman Al Shaya, Hisham A. Badreldin, Raed Kensara, Abdullah F. Alharthi, Jahad Alghamdi, Ahad Alawad, Rand Alotaibi, Abdullah Kharbosh, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Mohammed Almusallam, Ghada Albarrak, Ibrahim Al Sulaihim, Bader Alanazi, Bodoor S. Al-Dosari, Ramesh Vishwakarma, Alawi S. Alsaeedi, Ghassan Al Ghamdi, Hadeel Alkofide, Hasan M. Al-Dorzi
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
BackgroundThe cardiovascular complications of Coronavirus Disease 2019 (COVID-19) may be attributed to the hyperinflammatory state leading to increased mortality in patients with COVID-19. HMG-CoA Reductase Inhibitors (statins) are known to have plei
Externí odkaz:
https://doaj.org/article/497e868d0a4c41eabcb9464903f68d69
Autor:
Shmeylan Al Harbi, Raed Kensara, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Abdullah Al Harthi, Ramesh Vishwakarma, Alaa M. Alenazi, Abdulmajed Almutairi, Omar Alshaya, Sultan Alraddadi, Tareq Al Sulaiman, Latifah Aldakkan, Reem Mahboob, Kholoud Alaamer, Abdulrahman Alissa, Awatif Hafiz, Nada Aldhayyan, Sara Althewaibi, Farhan Alenezi, Nadeen Y. Alkhotani, Sara A. Alghamdi, Abeer A. Alenazi, Khalid Al Sulaiman
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Purpose Coagulation abnormalities are one of the most important complications of severe COVID-19, which might lead to venous thromboembolism (VTE). Hypercoagulability with hyperfibrinogenemia causes large vessel thrombosis and major thromboembolic se
Externí odkaz:
https://doaj.org/article/3380178905e34bba9547df8771fb26cc
Autor:
Abdullah F. Al Harthi, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Raghdah S. Alenezi, Shmeylan Al Harbi, Jawaher Gramish, Raed Kensara, Awattif Hafidh, Huda Al Enazi, Ahad Alawad, Rand Alotaibi, Abdulaziz Alshehri, Omar Alhuthaili, Ramesh Vishwakarma, Khalid bin Saleh, Thamer Alsulaiman, Rahaf Ali Alqahtani, Sajid Hussain, Saja Almazrou, Khalid Al Sulaiman
Publikováno v:
Journal of Intensive Care Medicine. 37:1238-1249
Background Aspirin is widely used as a cardioprotective agent due to its antiplatelet and anti-inflammatory properties. The literature has assessed and evaluated its role in hospitalized COVID-19 patients. However, no data are available regarding its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4a7f86fcc05217a884647f3fa8e18cf
https://doi.org/10.1177/08850666221093229
https://doi.org/10.1177/08850666221093229
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Shmeylan Al Harbi, Abdulrahman Al Shaya, Hisham A. Badreldin, Raed Kensara, Abdullah Al Harthi, Jahad Alghamdi, Ahad Alawad, Rand Alotaibi, Abdullah Kharbosh, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Mohammed Almusallam, Ghada Albarrak, Ibrahim Al Sulaihim, Bader Alanazi, Bodoor S. Al-Dosari, Ramesh Vishwakarma, Alawi S. Alsaeedi, Ghassan Al Ghamdi, Hasan M Al-Dorzi
Background The cardiovascular complications of Severe Coronavirus Disease 2019 (COVID-19) may be attributed to the hyperinflammatory state leading to increased mortality in patients with COVID-19. Statins are known to have pleiotropic and anti-inflam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95aa4aafaf963ac55c2e8fa22f624d44
https://doi.org/10.21203/rs.3.rs-828175/v3
https://doi.org/10.21203/rs.3.rs-828175/v3
Autor:
Saja Almazrou, Rahaf Ali Alqahtani, Awattif Hafidh, Jawaher Gramish, Raed Kensara, Ohoud Aljuhani, Abdulaziz Alshehri, Thamer Alsulaiman, Ali F. Altebainawi, Rand Alotaibi, Khalid Bin Saleh, Ramesh Vishwakarma, Ahad Alawad, Omar Alhuthaili, Raghdah S. Alenezi, Khalid Al Sulaiman, Huda Al Enazi, Abdullah Al Harthi, Sajid Hussain, Ghazwa B. Korayem, Shmeylan Al Harbi
BackgroundMultiple medications with anti-inflammatory effects have been used to manage the hyper-inflammatory response associated with COVID-19. Aspirin is used widely as a cardioprotective agent due to its antiplatelet and anti-inflammatory properti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9f9d1b5192c95c723edb6d5a525161e
https://doi.org/10.21203/rs.3.rs-872891/v1
https://doi.org/10.21203/rs.3.rs-872891/v1